CBD Improved Survival in Pancreatic Cancer Mice and Changed Gut Bacteria

What the researchers found

Only CBD alone improved survival in KPC mice (a genetic model that mimics human pancreatic cancer). The THC-CBD combination, which synergistically killed pancreatic cancer cells in lab dishes, did not translate to survival benefits in living mice. CBD treatment was linked to changes in gut microbiota composition and bile acid profiles.

Why it matters

Pancreatic cancer has among the worst survival rates of any cancer. The finding that CBD specifically altered gut bacteria and bile acid metabolism in surviving mice opens a new line of investigation into how cannabinoids might influence cancer outcomes through the gut-liver axis rather than direct tumor killing.

The numbers in context

CBD and THC synergistically reduced PDAC cell viability in vitro, but only CBD monotherapy improved survival in KPC mice. CBD effects on gut microbiota and bile acid profiles were distinct from those of THC alone or the combination.

How the study worked

Researchers tested THC and CBD individually and combined in PDAC cell lines and in KPC mice that spontaneously develop pancreatic cancer. Fecal microbiota was characterized by 16S rRNA gene sequencing, and bile acid profiling was performed using mass spectrometry on fecal, cecal, and plasma samples.

What this study cannot tell us

KPC mice, while a strong model, do not perfectly replicate human pancreatic cancer. The study cannot determine whether the gut microbiota and bile acid changes caused the survival benefit or were simply correlated with it. Dosing and route of administration in mice may not translate directly to humans.

How to read the evidence

Animal study using a well-validated genetic mouse model of pancreatic cancer. Results are promising but require human clinical validation.

When this study was published

Published in 2025.

The bigger picture

This study challenges the common assumption that THC-CBD combinations are always better than either compound alone. The disconnect between cell culture results (where the combo worked best) and animal results (where only CBD helped) highlights the importance of studying whole-organism effects.

Questions still open

• Could targeting bile acid metabolism directly produce similar benefits? Why did the THC-CBD combination fail in vivo despite succeeding in vitro? Would CBD work alongside standard chemotherapy?

Common questions

Read the original research

Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota.

International journal of molecular sciences, 26(16)

Citation

Malhotra, Pratibha; Palanisamy, Ranjith; Panda, Arunima; Casari, Ilaria; Tirnitz-Parker, Janina E E; O'Gara, Fergal; Trengove, Robert; Ragunath, Krish; Caparros-Martin, Jose A; Falasca, Marco. (2025). Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota.. International journal of molecular sciences, 26(16). https://doi.org/10.3390/ijms26167733

Explore the wider topic

• CBD Oil Quality Guide: How to Avoid Snake Oil
• Anxiety After Quitting Weed: When to Consider Medication
• Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
• Cannabis for Chronic Pain: What the Research Actually Supports
• Cannabis and Epilepsy: The Epidiolex Story and What It Means
• Does CBD Actually Work for Anxiety? What the Evidence Shows
• Does CBD Help with Weed Withdrawal? What Studies Show
• CBD vs THC: The Differences That Actually Matter
• The Proven Medical Benefits of Cannabis: What Research Supports
• Quitting Weed Before Surgery
• Weed and Medications: What Changes When You Quit
• Quitting Weed During Pregnancy: What You Need to Know
• Quitting Weed While Pregnant: What You Need to Know
• Cannabis and Older Adults: Risks Seniors Should Know
• Cannabis and Breastfeeding: THC in Breast Milk